心脑血管病来的慢病管理.ppt

  1. 1、本文档共149页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
* BP Reductions as Little as 2 mm Hg Reduce of the Risk of CV Events up to 10% Data from a meta-analysis of 61 prospective, observational studies has also provided powerful evidence that throughout middle and old age, BP is strongly and directly related to vascular mortality.7 These findings show, for example, that a 10 mm Hg lower systolic BP is associated over the long term with a 40% lower risk of stroke death and a 30% lower risk of death from ischemic heart disease (IHD) or other vascular causes. Importantly, within each decade of life between 40 and 89 years the proportional difference in the risk of vascular death associated with a given absolute difference in mean BP is roughly equivalent down to at least 115 mm Hg for systolic BP and 75 mm Hg for diastolic BP (below which there is little evidence). Thus, there was no evidence of a J curve across all middle and older age groups. Perhaps most striking are the practical implications of these data: even a small, 2 mm Hg fall in mean systolic BP would be associated with large absolute reductions in premature deaths and disabling strokes.7 As shown here, a 2 mm Hg lower mean systolic BP could lead to a 7% lower risk of IHD death and a 10% lower risk of stroke death. 7 Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913. Slide 17: LIIFE: Stroke Losartan reduced the risk of fatal and non-fatal stroke, a major cause of death and disability, by 25% compared with atenolol. This risk reduction was highly significant (p=0.0010).1 This cerebrovascular protective benefit in patients treated with losartan was greater than has been observed in trials of varying hypertensive patient populations in comparisons of CCB-based therapy with diuretic-based or beta blocker-based therapy.35 The superior risk reduction

文档评论(0)

152****6235 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档